Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects

Author： Khosravan Reza   Grabowski Brian A.   Wu Jing-Tao   Joseph-Ridge Nancy   Vernillet Laurent  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.8, 2006-01, pp. : 821-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout

By Schumacher Jr   H Ralph  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 893-903

Informa Healthcare

Access to resources Recommend Favorite

Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects

By Nunes Teresa  

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 328-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, tolerability and pharmacokinetics of 2‐pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 7, 2015-10 ,pp. : 429-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects

By Yin Ophelia Q.P.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite